Professor Paul Klenerman, Principal Investigator at Oxford Martin School’s Institute for Emerging Infections has been elected as a Fellow of the Academy of Medical Sciences.
The honour recognises outstanding contributions to the advancement of medical science, innovative application of scientific knowledge, or conspicuous service to healthcare.
Paul is Wellcome Trust Senior Research Fellow in Clinical Science at the Nuffield Department of Medicine. His research aims to understand T cell responses to viruses, especially hepatitis C virus and HIV. His research group aims to develop new vaccines against HCV for prevention and treatment of disease by applying their understanding of the role of host immune responses in determining the outcome of viral infections. They have also established a Translational Immunology lab at the John Radcliffe Hospital to try and bring some of these techniques closer to patients.
He is one of seven medical researchers at Oxford University who have been elected among the 44 new Fellows to the Academy of Medical Sciences announced by the academy on 7 May.
Professor Sir John Tooke, President of the Academy of Medical Sciences said: 'The Academy of Medical Sciences exists to promote the best of medical science for the benefit of society. Our new Fellows are recognised for their exceptional contribution and collectively represent the array of talent present in the UK medical science community. They will further strengthen the Academy and I look forward to working with them over the coming years.'
The new Fellows will be formally admitted to the Academy at a ceremony on Wednesday 26 June 2013.
- More about Paul Klenerman and his work at the Institute for Emerging Infections
- Video: Watch Paul demonstrate the way our immune systems work discussing the best way to boost our natural defences in an effort to fight infection from Hep C and HIV.